YorkBridge Wealth Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $318K | Sell |
1,461
-173
| -11% | -$37.7K | 0.08% | 175 |
|
|
2022
Q3 | $322K | Buy |
1,634
+199
| +14% | +$39.2K | 0.08% | 178 |
|
|
2022
Q2 | $307K | Buy |
1,435
+268
| +23% | +$57.3K | 0.08% | 186 |
|
|
2022
Q1 | $331K | Sell |
1,167
-24
| -2% | -$6.81K | 0.07% | 216 |
|
|
2021
Q4 | $449K | Buy |
1,191
+26
| +2% | +$9.8K | 0.1% | 161 |
|
|
2021
Q3 | $481K | Sell |
1,165
-80
| -6% | -$33K | 0.12% | 135 |
|
|
2021
Q2 | $461K | Sell |
1,245
-57
| -4% | -$21.1K | 0.12% | 133 |
|
|
2021
Q1 | $377K | Buy |
1,302
+281
| +28% | +$81.4K | 0.11% | 150 |
|
|
2020
Q4 | $255K | Sell |
1,021
-15
| -1% | -$3.75K | 0.09% | 169 |
|
|
2020
Q3 | $235K | Buy |
+1,036
| New | +$235K | 0.1% | 158 |
|
|
2019
Q3 | – | Sell |
-1,252
| Closed | -$178K | – | 269 |
|
|
2019
Q2 | $178K | Sell |
1,252
-11
| -0.9% | -$1.56K | 0.08% | 182 |
|
|
2019
Q1 | $183K | Buy |
1,263
+12
| +1% | +$1.74K | 0.08% | 172 |
|
|
2018
Q4 | $142K | Sell |
1,251
-33
| -3% | -$3.75K | 0.08% | 189 |
|
|
2018
Q3 | $171K | Sell |
1,284
-10
| -0.8% | -$1.33K | 0.08% | 188 |
|
|
2018
Q2 | $145K | Buy |
1,294
+44
| +4% | +$4.93K | 0.06% | 221 |
|
|
2018
Q1 | $133K | Buy |
1,250
+81
| +7% | +$8.62K | 0.06% | 237 |
|
|
2017
Q4 | $117K | Buy |
1,169
+78
| +7% | +$7.81K | 0.06% | 258 |
|
|
2017
Q3 | $118K | Buy |
1,091
+891
| +446% | +$96.4K | 0.06% | 239 |
|
|
2017
Q2 | $20K | Hold |
200
| – | – | 0.01% | 510 |
|
|
2017
Q1 | $18K | Hold |
200
| – | – | 0.01% | 529 |
|
|
2016
Q4 | $14K | Buy |
+200
| New | +$14K | 0.01% | 513 |
|